212Pb-PLE conjugate (Cellectar/Orano Med)

N/A

Report date: 2025/01/26 18:24:38
NME

Base Information

Drug Name212Pb-PLE conjugate (Cellectar/Orano Med)
Drug Alias Nameradioimmunotherapeutic-212Pb (Cellectar/Orano Med)lead 212Pb-phospholipid ether conjugate (Cellectar/Orano Med)
ClassificationRadiation-emitting productsSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellectar Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrano Med LlcCellectar Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A